D4: Survival free of major neurocognitive impairment atmid‐ to later childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in D4: Survival free of major neurocognitive impairment atmid‐ to later… compared with single course (moderate certainty).
1 finding from 1 review
Neurosensory disability in later childhood ‐ not measured · Infants of women diagnosed with gestational diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurosensory disability in later childhood ‐ not measured · Infants of women diagnosed with gestational diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurosensory disability in later childhood ‐ not measured · women with gestational diabetes mellitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perinatal (fetal and neonatal death) and later infant mortality · Infants of women diagnosed with gestational diabetes
Insulin showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with anti‐diabetic agent (low certainty).
1 finding from 1 review
Neurosensory disability · Infants of women diagnosed with gestational diabetes
Insulin showed no clear difference in neurosensory disability in later childhood (18 months) Mild… compared with anti‐diabetic agent (low certainty).
1 finding from 1 review
Later development of cardiovascular disease · pregnant women with pre‐existing type 1 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Later development of cardiovascular disease · pregnant women with pre‐existing type 1 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Later development of cardiovascular disease · pregnant women with pre‐existing type 1 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severe PPH (≥ 1000 mL) · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
It is very uncertain whether active changes severe primary PPH (clinically estimated or measured blood loss ≥… compared with expectant management of the third stage of labour (all women) (very low certainty).
1 finding from 1 review
Very severe primary PPH (clinically estimated or measured blood loss ≥ to 2500 mL at time of birth) · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
1 finding from 1 review
Maternal death · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
1 finding from 1 review
Maternal Hb < 9 g/dL 24‐72 hours postpartum · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
Active may leads to lower maternal Hb < 9 g/dL 24‐72 hours postpartum compared with expectant management of the third stage of labour (all women) (low certainty).
1 finding from 1 review
Admission to SCBU/NICU · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
Active showed no clear difference in admission to SCBU/NICU compared with expectant management of the third stage of labour (all women) (low certainty).
1 finding from 1 review
Neonatal jaundice requiring phototherapy or exchange transfusion · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
It is very uncertain whether active changes neonatal jaundice requiring phototherapy or exchange transfusion compared with expectant management of the third stage of labour (all women) (very low certainty).
1 finding from 1 review
Neonatal polycythaemia treated with dilutional exchange transfusion · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
1 finding from 1 review
Maternal infectious morbidity (chorioamnionitis and/or endometritis) · women with prelabour rupture of membranes at term (37 weeks' gestation or later)
Planned early birth may leads to lower maternal infectious morbidity (chorioamnionitis and/or endometritis) compared with expectant management (low certainty).
1 finding from 1 review
Caesarean section · women with prelabour rupture of membranes at term (37 weeks' gestation or later)
Planned early birth showed no clear difference in caesarean section compared with expectant management (low certainty).
1 finding from 1 review
Serious maternal morbidity or death · women with prelabour rupture of membranes at term (37 weeks' gestation or later)
1 finding from 1 review
Definite early‐onset neonatal sepsis · women with prelabour rupture of membranes at term (37 weeks' gestation or later)
It is very uncertain whether planned early birth changes definite early‐onset neonatal sepsis compared with expectant management (very low certainty).
1 finding from 1 review